Education and Training in Addiction Medicine and Psychology across Europe: A EUFAS Survey.

Addiction European Federation of Addiction Societies Medicine Psychology Training

Journal

European addiction research
ISSN: 1421-9891
Titre abrégé: Eur Addict Res
Pays: Switzerland
ID NLM: 9502920

Informations de publication

Date de publication:
09 Aug 2023
Historique:
received: 18 08 2022
accepted: 31 05 2023
medline: 10 8 2023
pubmed: 10 8 2023
entrez: 9 8 2023
Statut: aheadofprint

Résumé

Training in addiction medicine and addiction psychology is essential to ensure the quality of treatment for patients with substance use disorders. Some earlier research has shown varying training between countries, but no comprehensive study of addiction training across Europe has been performed. The present study by the European Federation for Addiction Societies (EUFAS) aimed to fill this gap. A Delphi process was used to develop a questionnaire on specialist training in addiction treatment in 24 European countries. The final questionnaire consisted of 14 questions on either addiction medicine or addiction psychology, covering the nature and content of the training and institutional approval, the number of academic professorial positions, and the estimated number of specialists in each country. Information was not received from all countries, but six (Belgium, Denmark, Ireland, Italy, Poland, and Romania) reported no specialized addiction medicine training, while 17 countries did. Seven countries (Belgium, France, Ireland, Italy, Russia, Switzerland, and the Netherlands) reported no specialized addiction psychology training, while 14 countries did. Training content and evaluation methods varied. Approval was given either by governments, universities, or professional societies. Eighteen countries reported having professorships in addiction medicine and 12 in addiction psychology. The number of specialists in addiction medicine or psychology varied considerably across the countries. The survey revealed a large heterogeneity in training in addiction medicine and addiction psychology across Europe. Several countries lacked formal training, and where formal training was present, there was a large variation in the length of the training. Harmonization of training, as is currently the case for other medical and psychology specializations, is warranted to ensure optimal treatment for this under-served patient group.

Identifiants

pubmed: 37557089
pii: 000531502
doi: 10.1159/000531502
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1-11

Informations de copyright

© 2023 S. Karger AG, Basel.

Auteurs

Jørgen G Bramness (JG)

Department of Alcohol, Tobacco and Drugs, Norwegian Institute of Public Health, Oslo, Norway.
Institute Clinical of Medicine, UiT - the Arctic University of Norway, Tromsø, Norway.
Norwegian National Advisory Unit on Concurrent Substance Abuse and Mental Health Disorders, Innlandet Hospital Trust, Brumunddal, Norway.

Marja Leonhardt (M)

Norwegian National Advisory Unit on Concurrent Substance Abuse and Mental Health Disorders, Innlandet Hospital Trust, Brumunddal, Norway.
Faculty of Health Studies, VID - Specialized University, Oslo, Norway.

Geert Dom (G)

Collaborative Antwerp Psychiatric Research Institute (CAPRI), University of Antwerp, Antwerp, Belgium.

Albert Batalla (A)

Department of Psychiatry, University Medical Center, Utrecht Brain Center, Utrecht University, Utrecht, The Netherlands.

Gerardo Flórez Menéndez (G)

Addiction Treatment Unit, Department of Psychiatry, Complejo Hospitalario Universitario de Ourense, Galician Health System, Ourense, Spain.

Karl Mann (K)

Department of Addictive Behavior and Addiction Medicine, Central Institute of Mental Health, University of Heidelberg, Medical Faculty Mannheim, Mannheim, Germany.

Friedrich Martin Wurst (FM)

Department of Psychiatry and Psychotherapy, University of Basel, Basel, Switzerland.

Marcin Wojnar (M)

Department of Psychiatry, Medical University of Warsaw, Warsaw, Poland.

Colin Drummond (C)

National Addiction Centre, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.

Emanuele Scafato (E)

Osservatorio Nazionale Alcol, WHO Collaborating Centre for Health Promotion and Research on Alcohol and Alcohol-related Problems, Centro Nazionale Dipendenze e Doping, Istituto Superiore di Sanità, Rome, Italy.

Antoni Gual (A)

GRAC, Addictions Unit, Department of Psychiatry, Clinical Institute of Neuroscience, Hospital Clínic, RETICS, University of Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.

Cristina Maria Ribeiro (CM)

Faculty of Medicine, University of Lisbon, Lisbon, Portugal.

Olivier Cottencin (O)

Psychiatry and Addiction Medicine Department, University Lille, Inserm U-1772 (LiNC), CHU Lille, Lille, France.

Ulrich Frischknecht (U)

Department of Addictive Behavior and Addiction Medicine, Central Institute of Mental Health, University of Heidelberg, Medical Faculty Mannheim, Mannheim, Germany.
German Institute of Addiction and Prevention Research, Catholic University of Applied Sciences NRW, Cologne, Germany.

Benjamin Rolland (B)

Service Universitaire d'Addictologie de Lyon, CH Le Vinatier, Hospices Civils de Lyon, Bron, France.
Inserm U1028, CNRS UMR5292, Université Claude Bernard Lyon 1, Bron, France.

Classifications MeSH